(Q34617917)

3 August 2017

1 reference

title

Clinical pharmacology of omeprazole (English)

1 reference

3 August 2017

1 reference

1 reference

Howden CW

1

1 reference

3 August 2017

1 January 1991

1 reference

Clinical Pharmacokinetics

3 August 2017

1 reference

3 August 2017

20

1 reference

3 August 2017

38-49

1 reference

3 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199120010-00003

3 August 2017

0 references

cites work

Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis

1 reference

12 December 2020

Effect of single dose of omeprazole on the gastrointestinal peptide response to food

1 reference

12 December 2020

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

1 reference

12 December 2020

Biliary excretion of intravenous [14C] omeprazole in humans

1 reference

12 December 2020

Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules

1 reference

12 December 2020

Oral pharmacokinetics of omeprazole

1 reference

12 December 2020

Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.

1 reference

12 December 2020

The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis

1 reference

12 December 2020

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

1 reference

12 December 2020

Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.

1 reference

12 December 2020

The gastric H+,K+-ATPase: the site of action of omeprazole

1 reference

12 December 2020

Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists

1 reference

12 December 2020

Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group

1 reference

12 December 2020

Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage

1 reference

12 December 2020

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

12 December 2020

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

12 December 2020

Pharmacokinetics of [14C]omeprazole in patients with impaired renal function

1 reference

12 December 2020

Omeprazole inhibits elimination of diazepam

1 reference

12 December 2020

Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole

1 reference

12 December 2020

Inhibition by omeprazole of adrenocortical response to ACTH: clinical studies and experiments on bovine adrenal cortex in vitro

1 reference

12 December 2020

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

1 reference

12 December 2020

Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer

1 reference

12 December 2020

Regression of Barrett's epithelium with omeprazole

1 reference

12 December 2020

Omeprazole: mode of action and effect on acid secretion in animals

1 reference

12 December 2020

Omeprazole: effects on oxidative drug metabolism

1 reference

12 December 2020

Evaluation of omeprazole in reflux oesophagitis

1 reference

12 December 2020

The effects of omeprazole on endocrine function in man.

1 reference

12 December 2020

Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine Treatment

1 reference

12 December 2020

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

1 reference

12 December 2020

Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer.

1 reference

12 December 2020

The effect of omeprazole on insulin induced gastric secretion in man

1 reference

12 December 2020

Control of acute Zollinger-Ellison syndrome with intravenous omeprazole

1 reference

12 December 2020

Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification

1 reference

12 December 2020

Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis

1 reference

12 December 2020

The effect of 20 Mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentration in duodenal ulcer patients

1 reference

12 December 2020

The relationship between suppression of acidity and gastric ulcer healing rates

1 reference

12 December 2020

Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure

1 reference

12 December 2020

Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial

1 reference

12 December 2020

Propranolol steady-state pharmacokinetics are unaltered by omeprazole

1 reference

12 December 2020

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome

1 reference

12 December 2020

A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers

1 reference

12 December 2020

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

12 December 2020

Pharmacokinetics and metabolism of omeprazole in man.

1 reference

12 December 2020

Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials

1 reference

12 December 2020

The effect of antacids and metoclopramide on omeprazole absorption and disposition

1 reference

12 December 2020

Pharmacokinetics and metabolism of omeprazole in animals and man--an overview

1 reference

12 December 2020

Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

1 reference

12 December 2020

Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study

1 reference

12 December 2020

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

12 December 2020

Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief

1 reference

12 December 2020

Omeprazole: pharmacokinetics and metabolism in man.

1 reference

12 December 2020

Effect of daily oral omeprazole on 24 hour intragastric acidity

1 reference

12 December 2020

Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man

1 reference

12 December 2020

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

1 reference

12 December 2020

Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man

1 reference

12 December 2020

No effect of omeprazole-induced hypoacidity on the bioavailability of amoxycillin or bacampicillin

1 reference

12 December 2020

The physiology of gastric acid secretion

1 reference

12 December 2020

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

1 reference

12 December 2020

Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily

1 reference

12 December 2020

The anti-secretory effect and pharmacokinetics of omeprazole in chronic liver disease

1 reference

12 December 2020

Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole

1 reference

12 December 2020

10.2165/00003088-199120010-00003

Identifiers

DOI

1 reference

PubMed ID

2029801

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

2029801